Patients with a diagnosis of ATTRv amyloidosis with a documented TTR variant and neuropathy (baseline NIS of 5–130), a PND score of IIIb, a Karnofsky Performance Status score of ≥ 60%, and adequate liver and renal function. This evidence concerns the gene TTR and familial amyloid neuropathy.